RxDoctor Payments Data

Kristy Nguyen, MD

Family Medicine · Pensacola, FLNPI 1114422441

Payments from drug & device makers

$2,457in general payments, 2019–2025

Across 138 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • AstraZeneca$324
  • Pfizer$285
  • Lilly USA, LLC$281
  • Novo Nordisk$232
  • GSK$214
  • plus $558 from 14 others

What the payments were for

  • Food & beverage$2,457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,457 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$54,994
Medicare patients
233
Services billed
567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide51$61,585
TrulicityDulaglutide44$54,649
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$52,139
JardianceEmpagliflozin38$50,721
OzempicSemaglutide32$45,042
JanuviaSitagliptin Phosphate36$34,227
EliquisApixaban25$31,067
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$14,614
Advair HfaFluticasone Propion/Salmeterol21$12,779
JanumetSitagliptin Phos/Metformin Hcl11$12,251
MovantikNaloxegol Oxalate12$4,758
Gabapentin194$4,244
Omeprazole180$3,824
SynthroidLevothyroxine Sodium46$3,480
Humalog Kwikpen U-100Insulin Lispro11$3,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$281$116,23495 claims
GSKTrelegy Ellipta$214$52,13962 claims
Boehringer IngelheimJardiance$47$50,72138 claims
Novo NordiskOzempic$232$45,04232 claims
PfizerEliquis$285$31,06725 claims
AstraZenecaBreztri Aerosphere$324$14,61421 claims
AbbVieSynthroid$562$3,48046 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →